Overview

CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of CP4071 in treating patients who have locally advanced or metastatic soft tissue sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Herbert Irving Comprehensive Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Digitoxin